PharmaCyte Biotech, Inc.

Historical 13F Holders

Symbol
PMCB
CUSIP
71715X203
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 71715X203 since 12/18/2024, largest first.

Filer % of Class Filed
Ayrton Capital LLC 13G/A
9.9% 2/13/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Intracoastal Capital LLC 13G/A
4.99% 2/13/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 6 62.8 k $25.7 k
2026 Q2 29 763 k $586 k
2026 Q1 32 968 k $643 k
2025 Q4 28 984 k $712 k
2025 Q3 23 433 k $420 k
2025 Q2 24 577 k $632 k
2025 Q1 26 568 k $710 k
2024 Q4 23 601 k $934 k
2024 Q3 27 826 k $1.58 M
2024 Q2 29 1.03 M $2.02 M
2024 Q1 30 978 k $2.32 M
2023 Q4 33 1.09 M $2.35 M
2023 Q3 32 1.14 M $2.40 M
2023 Q2 30 1.21 M $3.47 M
2023 Q1 30 3.53 M $10.2 M
2022 Q4 33 3.45 M $10.1 M
2022 Q3 33 4.98 M $12.0 M
2022 Q2 34 3.92 M $8.79 M
2022 Q1 29 3.84 M $8.83 M
2021 Q4 31 3.47 M $8.68 M
2021 Q3 25 1.40 M $4.42 M